B-NHL 淋巴瘤 ; 细胞淋巴瘤 ; 细胞非霍奇金淋巴瘤 ; 非霍奇金淋巴瘤
小细胞性B-NHL small B cell lymphomas
B-CELL NHL 细胞非霍奇金淋巴瘤 ; b细胞nhl
b cell nhl b细胞性nhl
While, monoclonal antibody against CD20 antigen on the membrane of B-cell NHLs and normal B-lymphocyte showed satisfactory curative effect in clinical treatment of NHL.
针对B淋巴瘤细胞和B淋巴细胞表面CD 20抗原的单克隆抗体治疗NHL取得了较好的效果。
Clonal immunoglobulin heavy chain gene rearrangement can be used as a effective diagnostic molecular marker for B-NHL.
克隆性免疫球蛋白重链基因重排检测可以作为诊断恶性B细胞性非霍奇金淋巴瘤的有效分子标志。
Conclusion Short term and intensive chemotherapy can improves the efficacy and survival rate of childhood and adolescent B-NHL, especially for advanced stage patients.
结论短疗程、高强度化疗结合中枢神经系统预防的治疗策略能明显改善儿童青少年B - NHL患者的疗效和生存率，特别是对晚期患者的疗效更明显。
应用推荐